HCA Healthcare and Tenet Healthcare, for-profit chains that collectively own 240 hospitals, both said their revenue and ...

European regulators said that a Duchenne gene therapy should not be approved, imperiling the treatment that is also facing ...

As the Trump administration reshapes biomedicine, it wants to change how scientists test drug safety: animal research.

Preauthorization is about to enter the lives of many seniors who have chosen traditional Medicare over MA, write former CMS ...

Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ ...

President Trump wants to end homelessness in America. His plan? Make it easier to involuntarily treat people with serious ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.

President Trump wants to make it easier to involuntarily treat people with serious mental illnesses, but critics say the ...

The federal government has approved more than $4 billion in extra Medicaid funds that will be routed to hospitals, doctors, ...

As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are ...

President Trump is threatening to withhold funds from supervised drug consumption sites and potentially pursue criminal penalties against them.